Pseudomonas aeruginosa is commonly associated with progressive pulmonary disease in patients with cystic fibrosis (CF) [1] . Once established, colonization is rarely eliminated. P aeruginosa bacteremia virtually never occurs in these patients. To gain a better understanding of this peculiar host-parasite interaction, a number of investigators have studied the humoral immune response of patients with CF to P aeruginosa antigens. Hoiby and Axelsen [2] demonstrated by crossed immunoelectrophoresis that chronically colonized patients developed precipitating antibodies in their sera, with as many as 22 distinct specificities. These authors made no attempt to identify the antigens.
Hoiby later observed [3] a positive correlation between the severity of infection and the number of
Received for publication July 1, 1983, and in revised form October 3, 1983.
Informed consent was obtained from all patients in this study. The guidelines for human experimentation of the University of British Columbia and the Medical Research Council of Canada were followed in the conduct of this research.
This work was supported in part by the Medical Research Council of Canada and the Canadian Cystic Fibrosis Foundation.
We thank the staff of Children's Hospital Cystic Fibrosis Assessment Clinic in British Columbia for collecting the blood and Shannon Marques da Silva for typing the manuscript.
Please address requests for reprints to Dr Robert E. W. Hancock, Department of Microbiology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1W5.
precipitins. Other authors have reported fewer different types of antibody [4-8], but it has generally
been concluded that patients with CF are capable of mounting an immune response to P aeruginosa antigens. Such patients may have serum antibodies to exotoxin A [9, 10], protease [10] , mucoid exopolysaccharide [11] [12] [13] , or three uncharacterized cell-envelope proteins [14] with molecular weights of 58,500 (possibly flagellin [15] ), 37,500, and 34,000, respectively.
Using both polyclonal and monoclonal antibodies, we have demonstrated that the outer-membrane proteins of P aeruginosa are strongly conserved [15, 16] . For example, polyclonal antibodies to proteins E, F, H2, and I react with all 17 serotypes included in the P aeruginosa International Antigen Typing Scheme [15] . Furthermore, monoclonal antibodies to proteins F and H2 react with all 17 serotype strains as well as with 16 isolates from patients with CF [16, 17] . In the present study we demonstrate that patients with CF who are colonized with P aeruginosa have substantial titers of antibody to outer-membrane proteins, and we identify some of the individual outer-membrane proteins to which these patients respond.
Materials and Methods
Antigen isolation. P aeruginosa PAO1 strain H103 was used for the isolation of outer mem-branes by the one-step procedure of Hancock and Carey [18] . Lipopolysaccharide (LPS) was isolated from strain H103 by the technique of Darveau and Hancock [19] . Antisera and antibodies. Sera were collected from 32 patients with CF and from 21 healthy adults; the latter group of specimens included 15 individual serum samples from volunteers at the Vancouver Red Cross and pooled sera from six laboratory volunteers who routinely handled strain H103. After informed consent had been obtained, venous blood was drawn from all donors and was allowed to clot at 23 C for 45 min. The specimens were removed and stored frozen at -70 C without an apparent reduction of antibody titer. Of the 32 patients with CF whose sera were analyzed, 13 had no history of colonization by P aeruginosa; their average age was 9.1 years (range, seven months to 26 years). Four patients (aged three, seven, 18, and 19 years) were first found to be colonized when blood was drawn for the present study. Fifteen patients (average age, 13.1 years; range, five to 24 years) had been colonized with P aeruginosa for 1.5 to nine years.
The antibodies used as positive controls or for the identification of specific bands on Western immunoblots included the following monoclonal antibodies: MA1-8, specific for the LPS O-side chain of P aeruginosa serotype 5 [16] ; MA3-5, specific for the rough core of the LPS of P aeruginosa serotypes 5, 7, 9, 10, 14, and 16 [17] ; MA4-2, specific for protein F [17] ; and MA1-6, specific for protein H2 [16] .
Titration of antibodies. Antibodies were titrated by ELISA, with either outer membranes or LPS from strain H103 as the coating antigen; the ELISA was done as described previously [15, 16] except that dilutions of human serum in PBS were used as the first antibody and affinity-purified goat antibody to human IgA, IgG, and IgM (heavy and light chains) coupled to alkaline phosphatase (catalogue no. 15-10-07; KPL, Gaithersburg, Md) was used as the second antibody. A positive control, in which MA1-8 was used as antibody and outer membranes or LPS from strain H103 was used as antigen, was included on each microtiter plate. As negative controls, each serum was tested without precoating of ELISA wells with antigen; in this control system, background absorbance readings were obtained. Background responses were similar after the omission of serum or the second antibody from the ELISA. All sera were tested two to four times with consistent results. The ELISA titer was taken as the reciprocal log dilution of serum giving an absorbance value at 490 nm that was 30% of the positive control value. membrane components were separated on 140% acrylamide SDS-polyacrylamide gels after solubilization at 100 C for 5 min, as previously described [18] . These components were then transferred to nitrocellulose by the method of Towbin et al [20] and were allowed to react in turn with the following: fetal calf serum, which blocked nonspecific protein-binding sites on the nitrocellulose; a dilution of human serum that gave an ELISA titer of 102-103; an affinity-purified goat antiserum to human whole immunoglobulin coupled to alkaline phosphatase; and an alkaline-phosphatase histochemical substrate, Fast Red TR salt and Naphthol AS-MX phosphate; these experiments were performed essentially as described previously [ teers who routinely handled strain H103 contained low titers of antibody (10') to both outer membranes and LPS; this finding demonstrated that contact with P aeruginosa was not in itself sufficient to cause elevated serum antibody titers. When various epidemiologic factors were considered, a highly significant correlation (P < 0.002) was found between the presence of antibodies to outer-membrane antigens of P aeruginosa in the patients' sera and (1) documented colonization for more than one year by P aeruginosa and (2) the presence, as determined in a previous study [11] , of serum antibodies to mucoid exopolysaccharide (table 1). When only those patients known to be colonized with P aeruginosa were considered, geometric mean ELISA titers to outer membranes (1.3 x 105) were found to be much higher than titers to LPS (5.4 x 102) Q(2 = 11.6; P < 0.01). This result again suggested that the antibodies being measured against whole outer membranes were directed primarily against outer-membrane proteins rather than against LPS. However, titers of antibody to LPS were significantly higher (X2 = 15.0; P < 0.01) in sera from colonized patients (mean titer, 5.4 x 102) than in those from uncolonized patients (mean titer, 35) or controls (mean titer, 17). Presumably, these relatively low titers against LPS from strain H103 represented antibodies to common determinants in the LPS.
The presence of high levels of antibody to outermembrane proteins in patients with CF who are chronically colonized with P aeruginosa suggests that this antibody is ineffective against pulmonary disease in patients with CE Furthermore, these data suggest that immunization with outer membrane proteins would be of little value once chronic colonization by P aeruginosa was established in patients with CF. However, the possibility remains that immunization prior to colonization could be an effective preventive strategy. Protein F, which we have shown to be a common antigen in the strains of P aeruginosa studied so far [15] and to be surface exposed [17] , is clearly antigenic in humans (figure 2) and would be a reasonable candidate for a monovalent outer membraneprotein vaccine.
While this is the first definitive report of antibodies to specific outer-membrane proteins, Fernandes et al [14] used immunoprecipitation to demonstrate antibodies to two cell-envelope (outerplus-inner membrane) proteins of 58,500 daltons and 37,500 daltons in the sera of 13 of 60 patients with CF. However, these researchers did not characterize the specific location of these proteins in the bacterial cell envelope. This point is probably important, since we have recently shown by crossed immunoelectrophoresis that many precipitins in the sera of patients with CF are not directed against outer-membrane proteins [22] . Indeed, although the 58,500-dalton protein was the major polypeptide precipitated by CF sera in the study of Fernandes et al [14] , no major outer-membrane protein of this molecular mass exists in P aeruginosa [18] . We have proposed that this polypeptide is flagellin [15] , which, although attached to the cell envelope, is not a cell-envelope protein.
Despite the slight contamination of the outer membranes of strain H103 by flagellin [15] , we observed only small amounts of antibody to flagellin in sera from patients with CF in the present study. In contrast, a rabbit hyperimmunized with outer membranes had large quantities of antibody to flagellin [15] .
We recently showed that a large proportion of P aeruginosa isolates from patients with CF are nontypable by the Fisher typing scheme, serum sensitive, and deficient in LPS O-side chains [23] . We postulated that the serum susceptibility of these strains may explain in part why pseudomonas bacteremia is rare among patients with CE The high titers of circulating antibodies to outermembrane components could augment the bactericidal capacity of serum via the classical complement pathway. These antibodies could also function as opsonins, thereby enhancing phagocytosis and clearance of P aeruginosa organisms that gain access to the bloodstream.
Characterization of antibodies in sera from patients with CF. To obtain information about the presence of antibodies to individual outer-membrane proteins in the sera of patients with CF, we studied the interactions of these sera with Western electrophoretic blots of outer-membrane proteins. As discussed previously [15] , not all of the proteins were transferred quantitatively from SDS-polyacrylamide gels to nitrocellulose. In addition, the proteins were present in different amounts in the outer membranes. These two facts, together with the presumably different affinities of individual antibodies for their respective antigens, meant that we could not make quantitative conclusions about the amounts of specific antibodies in the sera. However, by use of monoclonal antibodies to specific outer-membrane proteins and by cotransfer of molecular-weight standards with outer-membrane proteins from slab gels to nitrocellulose and subsequent amido-black staining of both, we were able to draw precise conclusions about the specificities of some of the antibodies in the sera.
Of the 32 sera titrated by ELISA, only the 18 with the highest titers and serum CF17 were examined by this method. Representative data are shown in figure 2, lanes C, D, 
Discussion
These studies demonstrated that the outer membrane proteins of P aeruginosa are antigenic in patients with CF, since antibodies to a variety of individual outer-membrane proteins were found in the sera of such patients. The mean ELISA antibody titer against outer membranes in all patients with CF was 5 x 103, whereas the titer in patients with CF who were chronically colonized with P aeruginosa was >101. By way of comparison, rabbits hyperimmunized with outer membranes of P aeruginosa strain H103 (four injections of 50 ag at two-week intervals) had ELISA titers to heterologous outer membranes of ~ 105-106 [15] .
The data in the present study confirm earlier observations that the presence of circulating antibodies to P aeruginosa is an indicator of chronic respiratory disease in CF [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] (table 1) and that the extent of the immune response is related to the length of colonization with P aeruginosa [2, 3, 11] (table 1). The four patients with CF who were first found to be colonized with P aeruginosa when their blood was drawn for the present study had titers of antibody to outermembrane antigens comparable to those in patients with CF who had never been colonized (table 1) . Thus, chronic colonization apparently must be established before patients with CF mount a serum antibody response to P aeruginosa. A major unanswered question raised by this and similar studies is why patients with CF are unable to eradicate P aeruginosa despite such high levels of antibody to cell-surface antigens.
